Related references
Note: Only part of the references are listed.Daratumumab for treatment of pure red cell aplasia after allogeneic stem cell transplantation
Christina Rautenberg et al.
BONE MARROW TRANSPLANTATION (2020)
Successful treatment with daratumumab for post-HSCT refractory hemolytic anemia
Ehud Even-Or et al.
PEDIATRIC BLOOD & CANCER (2020)
Successful treatment of refractory red cell aplasia after allogeneic hematopoietic cell transplantation with daratumumab
Maria Queralt Salas et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2020)
Outcome of autoimmune cytopenia after hematopoietic cell transplantation in primary immunodeficiency
Su Han Lum et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2020)
Successful treatment of thrombocytopenia with daratumumab after allogeneic transplant: a case report and literature review
Yazan Migdady et al.
BLOOD ADVANCES (2020)
Infectious complications and NK cell depletion following daratumumab treatment of Multiple Myeloma
Hareth Nahi et al.
PLOS ONE (2019)
Refractory postallogeneic stem cell transplant pure red cell aplasia in remission after treatment with daratumumab
Srilakshmi Bathini et al.
AMERICAN JOURNAL OF HEMATOLOGY (2019)
Autoimmune Cytopenias in Pediatric Hematopoietic Cell Transplant Patients
Jessica A. Neely et al.
FRONTIERS IN PEDIATRICS (2019)
Post-allogeneic transplant Evans syndrome successfully treated with daratumumab
Richard Blennerhassett et al.
BRITISH JOURNAL OF HAEMATOLOGY (2019)
Hematopoietic stem cell transplantation for CD40 ligand deficiency: Results from an EBMT/ESID-IEWP-SCETIDE-PIDTC study
Francesca Ferrua et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2019)
Autoimmune hemolytic anemia and immune thrombocytopenia following hematopoietic stem cell transplant: A critical review of the literature
C. E. Neunert et al.
PEDIATRIC BLOOD & CANCER (2019)
Management of refractory autoimmune hemolytic anemia after allogeneic hematopoietic stem cell transplantation: current perspectives
Wilma Barcellini et al.
JOURNAL OF BLOOD MEDICINE (2019)
Risk Factors, Treatment, and Immune Dysregulation in Autoimmune Cytopenia after Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric Patients
Matthijs D. Kruizinga et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2018)
Current and emerging treatment options for autoimmune hemolytic anemia
Wilma Barcellini et al.
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2018)
Daratumumab in life-threatening autoimmune hemolytic anemia following hematopoietic stem cell transplantation
Catharina Schuetz et al.
BLOOD ADVANCES (2018)
Publication Bias: The Elephant in the Review
Jarrod E. Dalton et al.
ANESTHESIA AND ANALGESIA (2016)
The extended phenotype of LPS-responsive beige-like anchor protein (LRBA) deficiency
Laura Gamez-Diaz et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2016)
Autoimmune Hemolytic Anemia after Allogeneic Hematopoietic Stem Cell Transplantation: Analysis of 533 Adult Patients Who Underwent Transplantation at King's College Hospital
Meng Wang et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2015)
Autoimmune Hematological Diseases after Allogeneic Hematopoietic Stem Cell Transplantation in Children: An Italian Multicenter Experience
Maura Faraci et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2014)
Diagnostic and risk criteria for HSCT-associated thrombotic microangiopathy: a study in children and young adults
Sonata Jodele et al.
BLOOD (2014)
Long-lived plasma cells in autoimmunity: lessons from B-cell cepleting therapy
Matthieu Mahevas et al.
FRONTIERS IN IMMUNOLOGY (2013)
Autoimmune haemolytic anaemia complicating haematopoietic cell transplantation in paediatric patients: high incidence and significant mortality in unrelated donor transplants for non-malignant diseases
TA O'Brien et al.
BRITISH JOURNAL OF HAEMATOLOGY (2004)
The X-linked hyper-IgM syndrome - Clinical and immunologic features of 79 patients
JA Winkelstein et al.
MEDICINE (2003)
Share Paper
